Lowering radiation for low-risk HPV throat cancer patients
Part of Cancer, Ear, nose & throat, Mouth & dental clinical trials.
This trial tests whether giving less radiation after surgery is safe and effective for people with early-stage HPV-related throat cancer. It aims to reduce side effects while still controlling the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have HPV-positive throat cancer that was removed by surgery and had neck lymph nodes removed
- Your cancer is early stage with small tumors (T1-2) and limited lymph node involvement (N1, no more than 5 nodes, with very small spread outside the node)
- You haven't smoked in at least 6 months and smoked fewer than 15 pack-years in your life
- You start radiation within 8 weeks of surgery
- You have a good enough health status to undergo treatment (Karnofsky score 60 or higher)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a less intense (lower-dose) radiation plan, combined with chemotherapy, can control HPV-positive oropharyngeal (throat) cancer with fewer side effects. It targets people considered “low-risk” based on tumor size and lymph node involvement.
This study tries to see if less intense radiation can still work well for certain throat cancers linked to HPV. It is looking for people with early stage HPV-positive oropharynx cancer who may benefit from a lighter treatment plan.
This trial tests whether a lower dose of radiation to the neck is safe and effective for people with HPV-related oropharyngeal cancer. It may reduce side effects while still treating the cancer.
This trial tests whether using a lower intensity (reduced) chemo-radiation plan can work for some people with HPV-related oropharyngeal (throat) cancer without losing effectiveness. It may help reduce side effects while still controlling the cancer.
This trial tests a lower dose of radiation to certain neck areas for people with HPV-related oropharyngeal cancer. The goal is to see if reducing radiation can cause fewer side effects while still curing the cancer.
This trial tests whether using a de-escalated (lower/intensity-reduced) radiation approach can treat HPV-positive oropharyngeal squamous cell carcinoma. It may help reduce side effects while still keeping the cancer under control.
Hear when a new Oropharynx Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.